Startseite Improving pain treatment in children
Artikel Öffentlich zugänglich

Improving pain treatment in children

  • Hanna Karstensen , Nanna Brix Finnerup EMAIL logo und Harald Breivik
Veröffentlicht/Copyright: 1. Oktober 2016
Veröffentlichen auch Sie bei De Gruyter Brill

In this issue of the Scandinavian Journal of Pain, Brown and co-workers publish a randomized controlled trial comparing amitriptyline and gabapentin for the treatment of complex regional pain syndrome (CRPS) type I and neuropathic pain in children [1]. There is an urgent need for well-performed trials in paediatric pain to guide clinical practice, and this study is the first randomized trial to compare first-line drugs for these conditions in the paediatric population.

1 Complex regional pain syndrome (CRPS)

CRPS is a condition characterized by spontaneous and evoked pain, oedema, changes in skin colour and temperature and trophic changes in the distal extremities. CRPS type I typically occurs after minor trauma without affecting the nerves, whereas type II is associated with nerve damage, but CRPS may occur irrespective of the nerve innervation territory [2]. The diagnostic criteria for CRPS include continuing pain disproportional to any inciting event, at least three of sensory (hyperesthesia or allodynia), vasomotor, sudomotor or trophic symptoms and at least one sensory, vasomotor, sudomotor or trophic sign [3]. The pathophysiology is complex and may include both inflammatory and central sensitization mechanisms [2]. CRPS may also affect children and adolescents, in particular girls [4]. CRPS has a relatively good prognosis in children, and many have spontaneous resolution after some months although it is also reported that pain persists into adulthood in some patients [4].

2 Neuropathic pain

Neuropathic pain is pain caused by a lesion or disease of the somatosensory nervous system [5]. It includes phantom pain, postherpetic neuralgia, painful polyneuropathy, posttraumatic nerve injury pain and central pain related to multiple sclerosis, stroke or spinal cord injury. In contrast to CPRS, neuropathic pain is distributed in an area consistent with the nervous system lesion, and there should be negative sensory signs in the same neuroanatomically plausible area [6]. Neuropathic pain in children is rare and differs from the forms seen in adults [7]. In children, neuropathic pain mainly occurs following trauma, surgery or cancer. Even though the incidence of pain following nerve trauma is lower in children than in adults, it can still be severe and difficult to treat, and more focus on neuropathic pain in children is therefore needed [7].

3 Treating pain in children

Treatment recommendations for CRPS and neuropathic pain differ. However, in both conditions, the underlying disease should be treated whenever possible. In many cases, the treatment of chronic pain is symptomatic and should balance effects and side effects. Often a multidimensional treatment approach is used, including both pharmacological and psychological treatments. For CRPS, exercise and physical therapy are the most important treatments, while pharmacological treatments can be used to facilitate mobilization and training. Recent treatment recommendations for neuropathic pain in adults include tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin and gabapentin, including extended release forms as first-line treatments, while tramadol, strong opioids, lidocaine 5% patches, capsaicin 8% patches, and botulinum toxin A are second- and third-line treatment options [8].

There are no evidence-based treatment recommendations for CRPS and neuropathic pain in children and the treatment is based on recommendations for adults. Therefore, the study by Brown et al. is a very important contribution to the field. The current study investigated the effect of amitriptyline 10 mg at bedtime compared with gabapentin 900 mg/day in three divided doses for CRPS type I (n = 20) and neuropathic pain (n = 14) in children [1]. Secondary outcomes were sleep disability and adverse events. Both amitriptyline and gabapentin significantly decreased pain for a treatment period of 6 weeks, with no statistically significant difference between the two drugs (p = 0.71). Both drugs also improved sleep to the same degree. There were very few adverse events related to the study medication. The very important and highly clinically relevant message from the study is that there is no difference in effects and side effects between gabapentin 900 mg and amitriptyline 10 mg in this paediatric population. As the authors also note, it is important to take into account the low number of patients, and it is possible that differences between the two drugs could be identified in a larger population, but recruitment to such a trial is very challenging.

The leading question is if the drugs are actually better than placebo? From clinical trials in adults, we know that placebo responses can be very high, with up to 50% pain reduction or more after placebo treatment. Of particular concern in relation to the particular study is that there is a good prognosis of CRPS in children and with the inclusion of patients with a pain duration of only 1 month, spontaneous recovery over the 6-week period of the trial is expected. Furthermore, the large age span (7–18 years) and thus presumably a large variation in weight in this population raise the question if the dosages used were therapeutic in all subjects as they will be lower than recommended in a large proportion of the study population [9]. The research team did not find it ethical to add a placebo treatment, which is very understandable, but the result is that it leaves us with this open question. Despite the limitations, the study presents a daily clinical problem and provides valuable information on the comparative efficacy of two drugs commonly used for treating neuropathic pain and CRPS.


DOI of refers to article: http://dx.doi.org/10.1016/j.sjpain.2016.05.039.



Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark.

  1. Conflicts of interest: The authors declare no conflict of interest related to this Editorial comment

References

[1] Brown SC, Johnston BC, Amaria K, Watkins J, Campbell F, Pehora C, McGrath PA. A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children. Scand J Pain 2016;13:156–63.Suche in Google Scholar

[2] Birklein F, Schlereth T. Complex regional pain syndrome-significant progress in understanding. Pain 2015;156:S94–103.Suche in Google Scholar

[3] Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, Barthel J, Costa B, Graciosa JR, Bruehl S, Reflex Sympathetic Dystrophy Syndrome Association. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Med 2013;14:180–229.Suche in Google Scholar

[4] Weissmann R, Uziel Y. Pediatric complex regional pain syndrome: a review. Pediatr Rheymatol Online J 2016;14:29.Suche in Google Scholar

[5] Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, Treede RS. A new definition of neuropathic pain. Pain 2011;152:2204–5.Suche in Google Scholar

[6] Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DL, Bouhassira D, Cruccu G, Freeman R, Hansson P, Nurmikko T, Raja SN, Rice AS, Serra J, Smith BH, Treede RD, Jensen TS. Neuropathic pain: an updated grading system for research and clinical practice. Pain 2016;157:1599–606.Suche in Google Scholar

[7] Howard RF, Wiener S, Walker SM. Neuropathic pain in children. Arc Dis Child 2014;99:94–9.Suche in Google Scholar

[8] Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14:162–73.Suche in Google Scholar

[9] Brown SC. Analgesic guidelines for infants and children. In: Gebhart GF, Schmidt RF, editors. Encyclopedia of pain. 2nd ed. Berlin and Heidelberg, New York: Springer-Verlag; 2013. p. 133–40.Suche in Google Scholar

Published Online: 2016-10-01
Published in Print: 2016-10-01

© 2016 Scandinavian Association for the Study of Pain

Artikel in diesem Heft

  1. Scandinavian Journal of Pain
  2. Editorial comment
  3. Increased deep pain sensitivity in persistent musculoskeletal pain but not in other musculoskeletal pain states
  4. Clinical pain research
  5. Increased deep pain sensitivity in persistent musculoskeletal pain but not in other musculoskeletal pain states
  6. Editorial comment
  7. Patient Reported Outcomes (PROs) are sensitive outcome-variables in patients with chronic pain: Importance of self-efficacy
  8. Observational study
  9. Using patient reported outcomes in oncology clinical practice
  10. Editorial comment
  11. Cortical reorganization of the healthy hand in upper-limb complex regional pain syndrome(CRPS): Is reorganizations of common beliefs about CRPS necessary?
  12. Original experimental
  13. An exploration into the cortical reorganisation of the healthy hand inupper-limb complex regional pain syndrome
  14. Editorial comment
  15. Is there hope for the most complicated chronic pain patients facing back surgery?
  16. Educational case report
  17. A preoperative interdisciplinary biopsychosocial opioid reduction program in patients on chronic opioid analgesia prior to spine surgery: A preliminary report and case series
  18. Editorial comment
  19. Pain management in the Emergency Department – Still a long way to go?
  20. Clinical pain research
  21. Mandatory documentation of pain in the emergency department increases analgesic administration but does not improve patients’ satisfaction of pain management
  22. Editorial comment
  23. Pain relief during childbirth: Efficacy and safety of prolonging labour-analgesia with morphine directly into the lumbar cerebro-spinal-fluid (CSF)
  24. Systematic review
  25. Prolonging the duration of single-shot intrathecal labour analgesia with morphine: A systematic review
  26. Editorial comment
  27. The intricate relationship amongst pain intensity, fear and avoidance
  28. Systematic review
  29. A meta-analysis of fear-avoidance and pain intensity: The paradox of chronic pain
  30. Editorial comment
  31. Local infiltration analgesia(LIA), risk of local anaesthetic systemic toxicity (LAST) and kidney failure from NSAID in elderly patients
  32. Topical review
  33. Local infiltration analgesia in knee and hip arthroplasty efficacy and safety
  34. Editorial comment
  35. Analysis of pain-intensity measurements
  36. Topical review
  37. How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance
  38. Editorial comment
  39. The relationship between chronic pain and cardiovascular disease: Squaring the circle?
  40. Systematic review
  41. Assessing the relationship between chronic pain and cardiovasculardisease: A systematic review and meta-analysis
  42. Editorial comment
  43. Optimists fare better when chronic pain strikes – Or does pain related disability make us pessimists?
  44. Observational study
  45. Constructs of health belief and disabling distal upper limb pain
  46. Editorial comment
  47. Attitude and belief of pain-therapists are important when trying to help chronic pain patients: The Norwegian version of the Pain Attitudes and Beliefs Scale (PABS) improved by Rasch analysis
  48. Observational study
  49. Rasch analysis resulted in an improved Norwegian version of the Pain Attitudes and Beliefs Scale(PABS)
  50. Editorial comment
  51. Anxiety could play a larger role than depression in migraine headache
  52. Clinical pain research
  53. The relative importance of anxiety and depression in pain impact in individuals with migraine headaches
  54. Editorial comment
  55. Bringing the lab to the people: Experimental pain testing in the general population
  56. Clinical pain research
  57. Pressure and cold pain threshold reference values in a large, young adult, pain-free population
  58. Editorial comment
  59. Improving pain treatment in children
  60. Clinical pain research
  61. A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children
  62. Editorial comment
  63. Gut gateway to generalized pain
  64. Original experimental
  65. A low fermentable oligo-di-mono saccharides and polyols(FODMAP) diet reduced pain and improve ddaily life in fibromyalgia patients
  66. Editorial comment
  67. Measuring outcomes of pain management
  68. Clinical pain research
  69. Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial
  70. Clinical pain research
  71. Construct validity and reliability of Finnish version of Örebro Musculoskeletal Pain Screening Questionnaire
  72. Observational study
  73. Total sleep deprivation and pain perception during cold noxious stimuli in humans
  74. Corrigendum
  75. Corrigendum to ‘Reliability of pressure pain threshold testing in healthy pain free young adults’ [Scand. J. Pain 9 (2015) 38–41]
Heruntergeladen am 3.10.2025 von https://www.degruyterbrill.com/document/doi/10.1016/j.sjpain.2016.09.001/html
Button zum nach oben scrollen